Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share
October 14 2019 - 2:30PM
Business Wire
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of
modeling and simulation solutions for the pharmaceutical,
biotechnology, chemicals, and consumer goods industries, today
announced that its board of directors has declared its next ongoing
quarterly cash dividend of $0.06 per share of the Company’s common
stock. The cash dividend will be distributed on Friday, November 1,
2019, to shareholders of record as of Friday, October 25, 2019.
Walt Woltosz, chairman of the board of directors, said, “This
dividend declaration is a continuation of the Board’s plan to
distribute a cash dividend of $0.06 per share per quarter. The
declaration of any future dividends will be determined by the board
of directors each quarter and will depend on earnings, financial
condition, capital requirements, and other factors.”
About Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of drug discovery
and development software as well as a leading provider of both
preclinical and clinical pharmacometric consulting services for
regulatory submissions and quantitative systems pharmacology models
for drug-induced liver injury and nonalcoholic fatty liver disease.
The company is a global leader focused on improving the ways
scientists use knowledge and data to predict the properties and
outcomes of pharmaceutical, biotechnology, and chemical agents. Our
software is licensed to and used in the conduct of drug research by
major pharmaceutical, biotechnology, chemical, and consumer goods
companies and regulatory agencies worldwide. Our innovations in
integrating new and existing science in medicinal chemistry,
computational chemistry, pharmaceutical science, biology, and
physiology into our software have made us the leading software
provider for physiologically based pharmacokinetic modeling and
simulation. For more information, visit our website at
www.simulations-plus.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191014005624/en/
Simulations Plus Investor Relations
Ms. Renee Bouche 661-723-7723 renee@simulations-plus.com
Hayden IR Mr. Cameron Donahue
651-653-1854 cameron@haydenir.com
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Sep 2023 to Sep 2024